No Result
View All Result
SUBMIT YOUR ARTICLES
  • Login
Thursday, October 2, 2025
TheAdviserMagazine.com
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal
No Result
View All Result
TheAdviserMagazine.com
No Result
View All Result
Home Market Research Business

market strategy: Tariff delay sparks relief rally in Indian pharma stocks: Sudip Bandyopadhyay

by TheAdviserMagazine
3 months ago
in Business
Reading Time: 4 mins read
A A
market strategy: Tariff delay sparks relief rally in Indian pharma stocks: Sudip Bandyopadhyay
Share on FacebookShare on TwitterShare on LInkedIn


“The uncertainty is not around demand or the price hike but the uncertainties are company specific. JSW Steel, we will definitely want to hear what is their strategy about Bhushan Steel, that is a huge problem which has been created in the recent past post the Supreme Court order and one needs to understand how that will get disentangled,” says Sudip Bandyopadhyay, Group Chairman, Inditrade Capital. What is your overall sense on the pharma pack because within that interesting developments with respect to the stock prices that yes, the largecap pharma companies are doing well, but it is the mid and the small end of the space that is picking up momentum in terms of the stock price performance and especially those beaten down names, maybe a case like Granules, Natco Pharma they have not participated much in the couple of quarters, but what a rebound. If you can help us analyse that is there anything that is changing in terms of the investor sentiment or the market is trying to look beyond two-three quarters and trying to pencil in that.Sudip Bandyopadhyay: Well, of course, what has changed significantly is the tariff announcement by President Trump. There was a sword hanging on pharma sector and at different levels different figures were being thrown around. But finally, when the announcement came, it talks about very high 200% or whatever but it is after two years. So, obviously people immediately started talking about the fact that probably it will never come because if something gets pushed back by two years obviously there is no threat of imminent tariff on pharma products, so that was a fantastic news for most Indian pharma companies because most of them or at least a lot of them have significant business in US.

They do manufacture in India and supply to US, so they would have been adversely affected by the tariff and since that is not happening, that was the point from where pharma actually we started seeing significant momentum in largecap and some midcap pharma companies. As far as overall pharma is concerned Sun Pharma does look good because some of the molecules which they were expected to commercialise a bit later in the year is getting preponed and the commercial launch is happening in US very-very soon and that kind of enthused the investors about Sun Pharma.

Overall, they have significant business in US as well as India and both the markets are expected to do good. The pricing pressure on generics is, of course, there but that has kind of reached a level where we have seen the worst.

Live Events

Of course, Glenmark did a landmark deal and it is not only for Glenmark, for the entire Indian pharmaceutical industry this was a landmark deal with R&D getting established and getting properly valued by global pharma players, so this was definitely landmark and of course, Glenmark investors were rewarded and will be rewarded further I am sure in terms of dividend or other some kind of payouts, so that is as far as Glenmark and Sun Pharma is concerned. But by and large Indian pharma can breathe a sigh of relief post the tariffs sword going away and it is back to business as usual and considering that most of the sectors are kind of still awaiting to know about the tariff and its implications, pharma is one sector where that has been taken care of. Hence, pharma is rallying, that is my view.What is your own sense when it comes to the metal pack and especially the steel because this time around not much expectation but going ahead even the industry body is looking out for a decent price hike from these levels. Help us understand that how you are analysing the impact of that on the stock prices in the times ahead.Sudip Bandyopadhyay: Well, it is definitely positive for the overall steel industry. We have to remember that globally also demand for steel is going up and naturally price hike in the domestic scenario is also expected. The uncertainty is not around demand or the price hike but the uncertainties are company specific. JSW Steel, we will definitely want to hear what is their strategy about Bhushan Steel, that is a huge problem which has been created in the recent past post the Supreme Court order and one needs to understand how that will get disentangled.

It is very critical for JSW Steel at this stage. Of course, coking coal prices of the entire industry will be interesting to understands the trend and what the management commentary is for multiple companies not only JSW Steel because that is a very-very critical ingredient as far as steel making is concerned.

By and large, we believe that the industry margins would have improved in this current quarter for which results will come out. Top line depends on company specific like JSW Steel had a scheduled maintenance, so obviously the volume will be low, but the margin improvement will be visible.



Source link

Tags: BandyopadhyaydelayIndianmarketPharmaRallyReliefsparksstocksStrategySudipTariff
ShareTweetShare
Previous Post

US Secures $15B Energy Deal With Italy

Next Post

Benefits for Indian Companies in 2025

Related Posts

edit post
Nuclear fusion was always 30 years away—now it’s a matter of when, not if, fusion comes online to power AI

Nuclear fusion was always 30 years away—now it’s a matter of when, not if, fusion comes online to power AI

by TheAdviserMagazine
October 2, 2025
0

The breakthrough scientific moment for fusion power—and the potential for nearly limitless electricity from a so-called star in a jar—came...

edit post
Expert breaks down the 2025 tax changes retirees should know

Expert breaks down the 2025 tax changes retirees should know

by TheAdviserMagazine
October 2, 2025
0

Listen and subscribe to Decoding Retirement on Apple Podcasts, Spotify, or wherever you find your favorite podcasts. Retirees face a...

edit post
Biden’s Florida legacy: An economic boom, a magnet for immigrants and a solidly conservative red state

Biden’s Florida legacy: An economic boom, a magnet for immigrants and a solidly conservative red state

by TheAdviserMagazine
October 2, 2025
0

After Paola Freites was allowed into the U.S. in 2024, she and her husband settled in Florida, drawn by warm...

edit post
Market trading guide: Buy Hindustan Zinc, Fortis Health and 2 more stocks for up to 9% gains – Stock Ideas

Market trading guide: Buy Hindustan Zinc, Fortis Health and 2 more stocks for up to 9% gains – Stock Ideas

by TheAdviserMagazine
October 2, 2025
0

India’s benchmark indices, the Nifty and Sensex, ended their eight-day losing streak, led by private banks, auto, and IT stocks....

edit post
Axis Securities gives Nifty target of 25,500, names Bharti Airtel and Lupin among top 15 picks

Axis Securities gives Nifty target of 25,500, names Bharti Airtel and Lupin among top 15 picks

by TheAdviserMagazine
October 2, 2025
0

Among small caps, Mahanagar Gas Ltd (MGL), Kirloskar Brothers, Sansera Engineering, and Kalpataru Projects International are Axis Securities’ top picks.The...

edit post
PepsiCo’s new challenge: Making its chips and sodas colorful without artificial dyes

PepsiCo’s new challenge: Making its chips and sodas colorful without artificial dyes

by TheAdviserMagazine
October 2, 2025
0

Pepsi has a new challenge: keeping products like Gatorade and Cheetos vivid and colorful without the artificial dyes that U.S....

Next Post
edit post
Benefits for Indian Companies in 2025

Benefits for Indian Companies in 2025

edit post
What To Do Right Away

What To Do Right Away

  • Trending
  • Comments
  • Latest
edit post
What Happens If a Spouse Dies Without a Will in North Carolina?

What Happens If a Spouse Dies Without a Will in North Carolina?

September 14, 2025
edit post
California May Reimplement Mask Mandates

California May Reimplement Mask Mandates

September 5, 2025
edit post
Does a Will Need to Be Notarized in North Carolina?

Does a Will Need to Be Notarized in North Carolina?

September 8, 2025
edit post
Who Needs a Trust Instead of a Will in North Carolina?

Who Needs a Trust Instead of a Will in North Carolina?

September 1, 2025
edit post
DACA recipients no longer eligible for Marketplace health insurance and subsidies

DACA recipients no longer eligible for Marketplace health insurance and subsidies

September 11, 2025
edit post
‘Quiet luxury’ is coming for the housing market, The Corcoran Group CEO says. It’s not just the Hamptons, Aspen, and Miami anymore

‘Quiet luxury’ is coming for the housing market, The Corcoran Group CEO says. It’s not just the Hamptons, Aspen, and Miami anymore

September 9, 2025
edit post
CAG Earnings: Key quarterly highlights from Conagra Brands’ Q1 2026 financial results

CAG Earnings: Key quarterly highlights from Conagra Brands’ Q1 2026 financial results

0
edit post
US moots 15% international student cap on institutions

US moots 15% international student cap on institutions

0
edit post
I replaced my mother-in-law’s roof without a contract — then she stiffed me for nearly K. What are my options?

I replaced my mother-in-law’s roof without a contract — then she stiffed me for nearly $20K. What are my options?

0
edit post
Treasury Secretary Bessent says GDP could take a hit from the government shutdown

Treasury Secretary Bessent says GDP could take a hit from the government shutdown

0
edit post
Bitcoin ETFs Soar With 6 Million Inflow as Ether ETFs Add  Million

Bitcoin ETFs Soar With $676 Million Inflow as Ether ETFs Add $81 Million

0
edit post
Are REITs A Good Investment Now? Pros And Cons Of Investing In REITs

Are REITs A Good Investment Now? Pros And Cons Of Investing In REITs

0
edit post
Bitcoin ETFs Soar With 6 Million Inflow as Ether ETFs Add  Million

Bitcoin ETFs Soar With $676 Million Inflow as Ether ETFs Add $81 Million

October 2, 2025
edit post
Nuclear fusion was always 30 years away—now it’s a matter of when, not if, fusion comes online to power AI

Nuclear fusion was always 30 years away—now it’s a matter of when, not if, fusion comes online to power AI

October 2, 2025
edit post
Expert breaks down the 2025 tax changes retirees should know

Expert breaks down the 2025 tax changes retirees should know

October 2, 2025
edit post
Jimmy Kimmel suspension hurts brand

Jimmy Kimmel suspension hurts brand

October 2, 2025
edit post
Treasury Secretary Bessent says GDP could take a hit from the government shutdown

Treasury Secretary Bessent says GDP could take a hit from the government shutdown

October 2, 2025
edit post
Stay Out of the Doghouse: 9 Lessons for Smarter Finances

Stay Out of the Doghouse: 9 Lessons for Smarter Finances

October 2, 2025
The Adviser Magazine

The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.

CATEGORIES

  • 401k Plans
  • Business
  • College
  • Cryptocurrency
  • Economy
  • Estate Plans
  • Financial Planning
  • Investing
  • IRS & Taxes
  • Legal
  • Market Analysis
  • Markets
  • Medicare
  • Money
  • Personal Finance
  • Social Security
  • Startups
  • Stock Market
  • Trading

LATEST UPDATES

  • Bitcoin ETFs Soar With $676 Million Inflow as Ether ETFs Add $81 Million
  • Nuclear fusion was always 30 years away—now it’s a matter of when, not if, fusion comes online to power AI
  • Expert breaks down the 2025 tax changes retirees should know
  • Our Great Privacy Policy
  • Terms of Use, Legal Notices & Disclosures
  • Contact us
  • About Us

© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal

© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.